Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 15 studies | 29% ± 9% | |
connective tissue cell | 5 studies | 37% ± 15% | |
adventitial cell | 4 studies | 52% ± 10% | |
extravillous trophoblast | 3 studies | 79% ± 9% | |
placental villous trophoblast | 3 studies | 47% ± 25% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipose | 4 studies | 34% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 89% | 5920.40 | 407 / 459 | 92% | 46.51 | 1028 / 1118 |
uterus | 86% | 13494.76 | 146 / 170 | 40% | 38.47 | 183 / 459 |
esophagus | 71% | 4601.48 | 1026 / 1445 | 52% | 12.15 | 96 / 183 |
stomach | 72% | 1952.23 | 257 / 359 | 50% | 13.78 | 144 / 286 |
bladder | 81% | 2706.76 | 17 / 21 | 37% | 8.14 | 186 / 504 |
intestine | 69% | 2990.29 | 665 / 966 | 38% | 9.08 | 198 / 527 |
skin | 64% | 2599.74 | 1163 / 1809 | 33% | 6.69 | 154 / 472 |
adipose | 97% | 11780.23 | 1163 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 5356.41 | 1244 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 2% | 25.18 | 5 / 328 | 85% | 39.80 | 151 / 178 |
ovary | 5% | 200.78 | 9 / 180 | 75% | 32.98 | 321 / 430 |
heart | 80% | 2959.86 | 685 / 861 | 0% | 0 | 0 / 0 |
thymus | 51% | 1438.98 | 333 / 653 | 23% | 4.03 | 141 / 605 |
lung | 23% | 648.45 | 132 / 578 | 39% | 10.35 | 453 / 1155 |
muscle | 49% | 1083.08 | 394 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 31% | 640.70 | 81 / 258 | 6% | 1.29 | 13 / 230 |
prostate | 18% | 562.45 | 45 / 245 | 13% | 1.49 | 67 / 502 |
tonsil | 0% | 0 | 0 / 0 | 29% | 8.56 | 13 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 11.52 | 8 / 29 |
kidney | 7% | 97.93 | 6 / 89 | 10% | 1.66 | 92 / 901 |
brain | 0% | 1.80 | 4 / 2642 | 5% | 0.97 | 33 / 705 |
spleen | 1% | 9.27 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 10.79 | 7 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.17 | 3 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060216 | Biological process | definitive hemopoiesis |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0048048 | Biological process | embryonic eye morphogenesis |
GO_0001527 | Cellular component | microfibril |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
Gene name | MFAP5 |
Protein name | Microfibrillar-associated protein 5 (MFAP-5) (MP25) (Microfibril-associated glycoprotein 2) (MAGP-2) Microfibril associated protein 5 Microfibril associated protein 5 (cDNA FLJ42377 fis, clone UTERU2035469, highly similar to Microfibrillar-associated protein 5) |
Synonyms | MAGP2 |
Description | FUNCTION: May play a role in hematopoiesis. In the cardiovascular system, could regulate growth factors or participate in cell signaling in maintaining large vessel integrity (By similarity). Component of the elastin-associated microfibrils . . |
Accessions | F5H2W4 ENST00000544889.1 F5GYX4 ENST00000537009.5 ENST00000359478.7 [Q13361-1] B3KW70 H0YG03 ENST00000543467.5 ENST00000433590.6 ENST00000535336.5 ENST00000396549.6 [Q13361-2] Q13361 H0YGS3 F5H1C0 ENST00000535411.5 F5H7Z2 F5H413 ENST00000540087.5 [Q13361-2] ENST00000543369.5 ENST00000544211.5 |